Fatty Liver Found on Imaging
An ultrasound, CT, or MRI finding should be connected with blood tests and fibrosis risk.
- Share when the problem started
- Bring prior testing and treatment details
Why Choose GastroDoxs for Fatty Liver Care?
Condition-specific evaluation, evidence-based choices, clear scope, and coordinated follow-up
Fibrosis Risk Comes First
Ultrasound can show liver fat but cannot reliably stage scarring.
- Condition-specific evaluation
- Clear explanation of treatment and follow-up
Metabolic and Liver Care Together
Weight, glucose, cholesterol, blood pressure, sleep, and activity affect liver progression and cardiovascular risk.
- Condition-specific evaluation
- Clear explanation of treatment and follow-up
Other Liver Causes Are Excluded
Viral hepatitis, alcohol, medicines, autoimmune disease, and inherited conditions can also affect liver tests.
- Condition-specific evaluation
- Clear explanation of treatment and follow-up
Monitoring Is Based on Risk
Follow-up differs for mild steatosis, indeterminate fibrosis, advanced fibrosis, and cirrhosis.
- Condition-specific evaluation
- Clear explanation of treatment and follow-up
What Happens After You Book a Fatty Liver Visit?
A clear path from scheduling and records review to a patient-specific care plan
Share Liver and Metabolic History
Review liver-test trends, weight, diabetes, cholesterol, blood pressure, sleep apnea, alcohol, medicines, and family history.
Bring Imaging and Laboratory Results
Bring ultrasound, CT, MRI, elastography, platelets, liver enzymes, bilirubin, albumin, glucose, A1C, and lipid results.
Stage Fibrosis Risk
Your clinician uses FIB-4, laboratory trends, elastography, MRI, and selected biopsy to estimate scarring risk.
Build a Liver-Protection Plan
You receive metabolic goals, treatment options, monitoring intervals, and cirrhosis surveillance guidance when needed.
GastroDoxs GutGuardians™
Your guardians. GastroDoxs GutGuardians™ is an elite team of board-certified gastroenterologists - a physician-led defense force of specialists, systems, and solution pathways working together to protect, detect, solve, and defend your digestive health through expert GI evaluation, advanced diagnostic screening, and endoscopic evaluation - commanded from your first concern to your last follow-up, and every critical stage in between.
GastroDoxs GutRescue Mission™
Your rescue plan. When your diagnosis is confirmed, GastroDoxs GutRescue Mission™ deploys at full force - a gastroenterologist-led intervention plan delivering advanced colonoscopy, upper endoscopy, capsule endoscopy, and precision biologic and medication management across the full range of digestive conditions and complex GI emergencies - fighting for you with everything we have.
Reasons to Schedule Fatty Liver Care
Book when symptoms, test results, current treatment, or the next step remains unclear
Persistent ALT or AST Elevation
Repeated abnormal liver enzymes deserve a cause-focused review.
- Share when the problem started
- Bring prior testing and treatment details
Diabetes, Obesity, or High Cholesterol
These conditions increase the chance of progressive metabolic liver disease.
- Share when the problem started
- Bring prior testing and treatment details
Possible Advanced Liver Disease
Low platelets, high liver stiffness, an enlarged spleen, swelling, jaundice, or confusion may signal advanced disease.
- Share when the problem started
- Bring prior testing and treatment details
Fatty Liver Care With GastroDoxs GI Specialists
This guidance was medically reviewed to help patients understand fatty-liver findings, abnormal liver enzymes, fibrosis risk, metabolic health, weight treatment, and long-term liver protection. Recommendations depend on the complete history, examination, test results, treatment response, and clinical urgency.
What Patients Can Expect
Fatty Liver Care Near Cypress, Katy, Brookshire, and Jersey Village
GastroDoxs provides liver-focused evaluation at Houston-area locations for abnormal liver tests, fatty-liver imaging findings, fibrosis assessment, metabolic treatment, and cirrhosis monitoring.
All locations accept most major insurance — Aetna, BCBS, Cigna, UnitedHealthcare, Medicare.
Book an Appointment →
Questions Before Booking Fatty Liver Care
Schedule evaluation after fatty liver disease is found on imaging, liver enzymes remain abnormal, FIB-4 is indeterminate or high, metabolic risks are present, or the fibrosis stage and follow-up plan are unclear.
Yes. Persistent ALT or AST elevation should be interpreted with platelets, bilirubin, albumin, metabolic risks, alcohol and medicine exposure, viral hepatitis testing, and fibrosis assessment. Normal enzymes do not rule out advanced fibrosis.
Ultrasound may show liver fat and exclude some structural problems, but it cannot reliably stage fibrosis or prove steatohepatitis. The next step may include FIB-4, elastography, MRI, or additional laboratory testing.
Transient elastography, often called FibroScan, estimates liver stiffness and may estimate liver fat. It helps stratify fibrosis risk, but results must be interpreted with blood tests, body size, inflammation, and the full clinical picture.
Expect review of liver-test trends, platelets, imaging, weight, diabetes, cholesterol, blood pressure, sleep apnea, alcohol, medicines, diet, activity, and symptoms. The plan focuses on fibrosis risk and metabolic treatment.
Yes. Weight, glucose, cholesterol, blood pressure, sleep, nutrition, and activity are central to metabolic liver care. Treatment should protect muscle and cardiovascular health while reducing liver risk.
Follow-up depends on fibrosis risk and treatment response. Lower-risk patients may be reassessed periodically, while diabetes, high FIB-4, elevated liver stiffness, advanced fibrosis, or cirrhosis requires closer monitoring.
Prompt evaluation is needed for jaundice, abdominal or leg swelling, confusion, vomiting blood, black stools, severe weakness, low platelets, or rapidly worsening liver tests. Severe symptoms require emergency care.
Yes. A plan may include a Mediterranean-style eating pattern, appropriate portions, fewer sugar-sweetened drinks and refined carbohydrates, regular activity, resistance exercise, metabolic treatment, and alcohol guidance.
Bring laboratory trends, imaging reports, elastography results, medicine and supplement lists, alcohol history, diabetes and cholesterol results, prior liver evaluations, and any family history of liver disease.
Yes. FIB-4, platelets, elastography, MR elastography, imaging, and selected liver biopsy can assess fibrosis and possible steatohepatitis. The result guides treatment intensity and surveillance.
Ultrasound may show liver fat and exclude some structural problems, but it cannot reliably stage fibrosis or prove steatohepatitis. The next step may include FIB-4, elastography, MRI, or additional laboratory testing.
Treatment can reduce progression risk by improving weight, diabetes, cholesterol, blood pressure, sleep apnea, activity, and alcohol exposure. Selected higher-risk patients may also qualify for specialist-directed medication treatment.
Ask what your fibrosis risk is, whether other liver diseases were excluded, which test should be repeated, what metabolic goals matter most, whether medicine is appropriate, and whether cirrhosis surveillance is needed.
Yes. Persistent ALT or AST elevation should be interpreted with platelets, bilirubin, albumin, metabolic risks, alcohol and medicine exposure, viral hepatitis testing, and fibrosis assessment. Normal enzymes do not rule out advanced fibrosis.
Book a Fatty Liver Evaluation
Schedule GastroDoxs care for fatty-liver findings, abnormal liver enzymes, fibrosis risk, metabolic health, weight treatment, and long-term liver protection. Bring prior records and a medication list so your clinician can explain the safest next step. Seek emergency care for confusion, vomiting blood, black stools, fainting, rapidly worsening jaundice, severe abdominal swelling, or fever with advanced liver disease.